Loading...

Insmed Incorporated Peer Comparison

Metric Value Ranking
Market Cap $14.2 Billion 2/18 BGNE
$20.2B
INSM
$14.2B
CERE
$8.2B
RVMD
$7.6B
ASND
$7.5B
HALO
$7.4B
BPMC
$6.6B
SWTX
$4.1B
RARE
$4.0B
RNA
$3.8B
APLS
$3.5B
EWTX
$2.4B
HRMY
$2.2B
JANX
$2.1B
AGIO
$1.9B
DAWN
$1.2B
KROS
$413.2M
FENC
$178.8M
Gross Margin 77% 14/18 KROS
100%
RNA
100%
JANX
100%
BPMC
98%
SWTX
93%
DAWN
92%
AGIO
91%
RARE
85%
HALO
83%
BGNE
83%
APLS
81%
ASND
81%
FENC
81%
INSM
77%
HRMY
77%
RVMD
0%
CERE
0%
EWTX
0%
Profit Margin -100% 13/18 AGIO
100%
DAWN
100%
HALO
47%
HRMY
25%
RVMD
0%
CERE
0%
EWTX
0%
BGNE
-12%
APLS
-33%
BPMC
-44%
FENC
-82%
RARE
-96%
INSM
-100%
ASND
-100%
SWTX
-100%
KROS
-100%
RNA
-100%
JANX
-100%
EBITDA margin -228% 14/18 DAWN
148%
HALO
56%
HRMY
39%
BGNE
-5%
BPMC
-26%
APLS
-38%
FENC
-67%
RARE
-95%
RVMD
-100%
CERE
-100%
EWTX
-100%
SWTX
-118%
ASND
-123%
INSM
-228%
AGIO
-1147%
RNA
-4171%
JANX
-8164%
KROS
-15118%
Quarterly Revenue $93.4 Million 7/18 BGNE
$1.0B
HALO
$290.1M
HRMY
$186.0M
APLS
$176.6M
RARE
$139.5M
BPMC
$128.2M
INSM
$93.4M
ASND
$63.6M
SWTX
$49.3M
DAWN
$20.1M
AGIO
$9.0M
FENC
$7.0M
RNA
$2.3M
JANX
$439,000
KROS
$388,000
RVMD
$0
CERE
$0
EWTX
$0
Quarterly Earnings -$220.5 Million 18/18 AGIO
$947.9M
HALO
$137.0M
HRMY
$46.1M
DAWN
$37.0M
FENC
-$5.7M
JANX
-$28.1M
EWTX
-$34.1M
KROS
-$53.0M
SWTX
-$53.5M
BPMC
-$56.3M
APLS
-$57.4M
RNA
-$80.4M
ASND
-$109.0M
BGNE
-$121.4M
CERE
-$131.9M
RARE
-$133.5M
RVMD
-$156.3M
INSM
-$220.5M
Quarterly Free Cash Flow -$184.6 Million 17/18 HALO
$113.9M
HRMY
$70.5M
BGNE
$54.7M
APLS
$34.1M
FENC
-$2.2M
JANX
-$2.3M
DAWN
-$5.0M
BPMC
-$13.7M
SWTX
-$16.0M
EWTX
-$27.9M
KROS
-$30.9M
RARE
-$56.1M
RNA
-$67.3M
AGIO
-$84.6M
CERE
-$119.9M
RVMD
-$133.9M
INSM
-$184.6M
ASND
-$0
Trailing 4 Quarters Revenue $343.0 Million 8/18 BGNE
$3.3B
HALO
$947.4M
HRMY
$681.9M
APLS
$675.9M
RARE
$522.7M
BPMC
$434.4M
ASND
$360.0M
INSM
$343.0M
SWTX
$135.5M
FENC
$49.6M
AGIO
$32.9M
DAWN
$28.8M
JANX
$13.0M
RNA
$10.1M
KROS
$651,000
RVMD
$0
CERE
$0
EWTX
$0
Trailing 4 Quarters Earnings -$864.3 Million 18/18 BGNE
$1.0B
HALO
$290.1M
HRMY
$186.0M
APLS
$176.6M
RARE
$139.5M
BPMC
$128.2M
INSM
$93.4M
ASND
$63.6M
SWTX
$49.3M
DAWN
$20.1M
AGIO
$9.0M
FENC
$7.0M
RNA
$2.3M
JANX
$439,000
KROS
$388,000
RVMD
-$0
CERE
-$0
EWTX
-$0
Quarterly Earnings Growth -39% 14/18 AGIO
1138%
DAWN
180%
HALO
67%
APLS
59%
BPMC
58%
ASND
39%
SWTX
33%
HRMY
20%
RARE
16%
RVMD
9%
CERE
-26%
EWTX
-33%
KROS
-34%
INSM
-39%
RNA
-54%
JANX
-143%
BGNE
-156%
FENC
-207%
Annual Earnings Growth 3% 12/18 AGIO
297%
FENC
93%
BPMC
76%
APLS
51%
DAWN
50%
HALO
28%
ASND
19%
RARE
13%
SWTX
12%
BGNE
7%
JANX
6%
INSM
3%
HRMY
1%
RVMD
-16%
KROS
-19%
CERE
-20%
EWTX
-38%
RNA
-45%
Quarterly Revenue Growth 18% 10/18 KROS
4750%
SWTX
783%
BPMC
127%
APLS
78%
RARE
42%
HALO
34%
BGNE
28%
AGIO
21%
ASND
20%
INSM
18%
HRMY
16%
FENC
7%
CERE
0%
EWTX
0%
DAWN
0%
RNA
-17%
JANX
-83%
RVMD
-100%
Annual Revenue Growth 10% 12/18 KROS
8038%
SWTX
487%
FENC
201%
JANX
129%
BPMC
89%
APLS
76%
ASND
72%
BGNE
29%
RARE
24%
HRMY
21%
AGIO
19%
INSM
10%
HALO
8%
RNA
4%
CERE
0%
EWTX
0%
DAWN
0%
RVMD
-100%
Cash On Hand $461.5 Million 4/18 BGNE
$2.7B
ASND
$687.4M
KROS
$530.7M
INSM
$461.5M
DAWN
$422.8M
APLS
$396.9M
HRMY
$387.4M
RNA
$370.2M
CERE
$320.4M
AGIO
$253.7M
RVMD
$201.3M
HALO
$154.3M
RARE
$150.6M
BPMC
$89.4M
SWTX
$84.5M
EWTX
$44.8M
FENC
$40.3M
JANX
$26.8M
Short Term Debt $10.5 Million 6/18 BGNE
$881.5M
ASND
$494.2M
BPMC
$45.0M
AGIO
$16.3M
HRMY
$15.0M
INSM
$10.5M
RARE
$10.4M
RVMD
$8.4M
APLS
$6.8M
RNA
$3.8M
CERE
$3.5M
KROS
$1.9M
JANX
$1.7M
SWTX
$1.2M
EWTX
$992,000
DAWN
$77,000
FENC
$7,000
HALO
-$0
Long Term Debt $989.4 Million 2/18 HALO
$1.5B
INSM
$989.4M
RARE
$829.7M
ASND
$372.5M
CERE
$364.8M
BPMC
$341.5M
BGNE
$220.0M
HRMY
$167.8M
APLS
$104.7M
RVMD
$78.3M
AGIO
$44.5M
JANX
$43.5M
KROS
$17.4M
SWTX
$5.7M
RNA
$3.8M
EWTX
$3.4M
DAWN
$2.5M
FENC
$0
PE -1.00 4/18 HALO
18.84
HRMY
15.11
AGIO
2.77
INSM
-1.00
BGNE
-1.00
RARE
-1.00
BPMC
-1.00
APLS
-1.00
ASND
-1.00
FENC
-1.00
RVMD
-1.00
SWTX
-1.00
KROS
-1.00
RNA
-1.00
CERE
-1.00
EWTX
-1.00
DAWN
-1.00
JANX
-1.00
PS 41.52 6/18 KROS
634.68
RNA
375.37
JANX
162.91
AGIO
56.92
DAWN
42.44
INSM
41.52
SWTX
30.27
ASND
19.05
BPMC
15.14
HALO
7.80
RARE
7.67
BGNE
6.09
APLS
5.25
FENC
3.60
HRMY
3.16
RVMD
-1.00
CERE
-1.00
EWTX
-1.00
PB 29.46 1/18 INSM
29.46
BPMC
21.01
HALO
16.33
APLS
14.96
CERE
14.51
RARE
11.33
SWTX
7.70
BGNE
5.88
EWTX
5.01
RVMD
4.83
HRMY
3.62
JANX
3.24
RNA
2.53
DAWN
2.20
AGIO
1.15
KROS
0.78
ASND
0.00
FENC
0.00
PC 30.86 7/18 JANX
79.46
BPMC
73.62
EWTX
54.63
SWTX
48.56
HALO
47.91
RVMD
37.56
INSM
30.86
RARE
26.63
CERE
25.56
ASND
10.97
RNA
10.26
APLS
8.94
BGNE
7.48
AGIO
7.37
HRMY
5.57
FENC
4.44
DAWN
2.89
KROS
0.78
Liabilities to Equity 3.25 3/18 HALO
3.68
RARE
3.42
INSM
3.25
BPMC
2.83
APLS
2.80
CERE
1.00
BGNE
0.70
HRMY
0.56
SWTX
0.14
RVMD
0.13
AGIO
0.10
KROS
0.09
RNA
0.09
DAWN
0.08
JANX
0.06
EWTX
0.05
ASND
0.00
FENC
0.00
ROA -0.42 16/18 AGIO
38%
HALO
19%
HRMY
15%
FENC
-2%
JANX
-9%
BPMC
-11%
BGNE
-15%
DAWN
-15%
RNA
-17%
EWTX
-24%
APLS
-28%
RVMD
-31%
KROS
-31%
RARE
-36%
CERE
-41%
INSM
-42%
ASND
-43%
SWTX
-45%
ROE -1.79 18/18 ASND
482%
HALO
87%
AGIO
41%
HRMY
24%
FENC
23%
JANX
-9%
DAWN
-16%
RNA
-19%
BGNE
-25%
EWTX
-25%
RVMD
-34%
KROS
-34%
BPMC
-41%
SWTX
-52%
CERE
-82%
APLS
-105%
RARE
-161%
INSM
-179%
Current Ratio 1.31 14/18 EWTX
22.82
JANX
17.86
DAWN
13.25
KROS
12.47
RNA
11.94
AGIO
10.85
RVMD
8.96
SWTX
7.98
HRMY
2.80
BGNE
2.43
CERE
2.00
APLS
1.36
BPMC
1.35
INSM
1.31
RARE
1.30
HALO
1.27
ASND
0.92
FENC
0.92
Quick Ratio 0.94 12/18 HALO
18.84
HRMY
15.11
AGIO
2.77
INSM
-1.00
BGNE
-1.00
RARE
-1.00
BPMC
-1.00
APLS
-1.00
ASND
-1.00
FENC
-1.00
RVMD
-1.00
SWTX
-1.00
KROS
-1.00
RNA
-1.00
CERE
-1.00
EWTX
-1.00
DAWN
-1.00
JANX
-1.00
Long Term Debt to Equity 2.05 3/18 HALO}
3.32
RARE}
2.39
INSM}
2.05
BPMC}
1.09
CERE}
0.65
APLS}
0.44
HRMY}
0.28
JANX}
0.07
BGNE}
0.06
RVMD}
0.05
AGIO}
0.03
KROS}
0.03
SWTX}
0.01
EWTX}
0.01
FENC}
0.00
RNA}
0.00
DAWN}
0.00
ASND}
-3.48
Debt to Equity 2.07 2/18 HALO
3.32
INSM
2.07
BPMC
1.23
CERE
0.65
APLS
0.47
BGNE
0.32
HRMY
0.31
RVMD
0.06
AGIO
0.04
KROS
0.04
JANX
0.04
RARE
0.03
SWTX
0.01
RNA
0.01
EWTX
0.01
FENC
0.00
DAWN
0.00
ASND
-8.10
Burn Rate 1.76 8/18 KROS
9.81
BGNE
7.71
FENC
7.03
APLS
6.27
RNA
4.54
ASND
2.66
CERE
2.17
INSM
1.76
SWTX
1.56
EWTX
1.30
RVMD
1.25
BPMC
1.10
RARE
0.89
JANX
0.89
AGIO
-0.27
HALO
-2.01
HRMY
-10.87
DAWN
-11.45
Cash to Cap 0.03 12/18 KROS
1.28
DAWN
0.35
FENC
0.23
HRMY
0.18
AGIO
0.14
BGNE
0.13
APLS
0.11
RNA
0.10
ASND
0.09
RARE
0.04
CERE
0.04
INSM
0.03
RVMD
0.03
HALO
0.02
SWTX
0.02
EWTX
0.02
BPMC
0.01
JANX
0.01
CCR 0.84 4/18 HRMY
1.53
CERE
0.91
RVMD
0.86
INSM
0.84
RNA
0.84
HALO
0.83
EWTX
0.82
KROS
0.58
RARE
0.42
FENC
0.38
SWTX
0.30
BPMC
0.24
JANX
0.08
AGIO
-0.09
DAWN
-0.13
BGNE
-0.45
APLS
-0.59
ASND
EV to EBITDA -69.25 14/18 HALO}
53.57
DAWN}
27.10
HRMY}
26.95
KROS}
1.67
RVMD}
-1.00
CERE}
-1.00
EWTX}
-1.00
AGIO}
-16.32
RARE}
-29.32
FENC}
-29.57
RNA}
-35.26
APLS}
-48.28
JANX}
-59.22
INSM}
-69.25
SWTX}
-69.44
ASND}
-118.75
BPMC}
-206.03
BGNE}
-379.98
EV to Revenue 43.09 4/18 RNA
339.53
JANX
162.66
AGIO
51.06
INSM
43.09
SWTX
29.70
DAWN
27.86
ASND
23.46
BPMC
15.83
HALO
9.23
RARE
7.40
BGNE
5.61
APLS
4.82
HRMY
2.86
FENC
2.79
RVMD
-1.00
CERE
-1.00
EWTX
-1.00
KROS
-150.88